Central and Peripheral Nervous System Complications of Vasculitis Syndromes from Pathology to Bedside: Part 2—Peripheral Nervous System
Authors:
- Gelsomina MansuetoGelsomina Mansueto
- Giuseppe LanzaGiuseppe Lanza
- Jessica FalletiJFJessica Falleti
- Pasquale OrabonaPOPasquale Orabona
- Danielle AlaouiehDADanielle Alaouieh
- Emily HongEHEmily Hong
- Sara GirolamiSGSara Girolami
- Marco MontellaMMMarco Montella
- Francesco FisicaroFFFrancesco Fisicaro
- Anna GaldieriAGAnna Galdieri
- Puneetpal SinghPSPuneetpal Singh
- Mario Di NapoliMNMario Di Napoli
- 23 February 2023
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 23 (3) , 83-107
Abstract
Purpose of Review Peripheral nervous system vasculitides (PNSV) are a heterogeneous group of disorders with a clinical subset that may differ in prognosis and therapy. We provide a comprehensive update on the clinical assessment, diagnosis, complications, treatment, and follow-up of PNSV. Recent Findings Progress in neuroimaging, molecular testing, and peripheral nerve biopsy has improved clinical assessment and decision-making of PNSV, also providing novel insights on how to prevent misdiagnosis and increase diagnostic certainty. Advances in imaging techniques, allowing to clearly display the vessel walls, have also enhanced the possibility to differentiate inflammatory from non-inflammatory vascular lesions, while recent histopathology data have identified the main morphological criteria for more accurate diagnosis and differential diagnoses. Overall, the identification of peculiar morphological findings tends to improve diagnostic accuracy by defining a clearer boundary between systemic and non-systemic neuropathies. Therefore, the definition of epineurium vessel wall damage, type of vascular lesion, characterization of lymphocyte populations, antibodies, and inflammatory factors, as well as the identification of direct nerve damage or degeneration, are the common goals for pathologists and clinicians, who will both benefit for data integration and findings translation. Nevertheless, to date, treatment is still largely empiric and, in some cases, unsatisfactory, thus often precluding precise prognostic prediction. In this context, new diagnostic techniques and multidisciplinary management will be essential in the proper diagnosis and prompt management of PNSV, as highlighted in the present review. Summary Thirty to fifty percent of all patients with vasculitis have signs of polyneuropathy. Neuropathies associated with systemic vasculitis are best managed according to the guidelines of the underlying disease because appropriate workup and initiation of treatment can reduce morbidity. Steroids, or in severe or progressive cases, cyclophosphamide pulse therapy is the standard therapy in non-systemic vasculitic neuropathies. Some patients need long-term immunosuppression. The use of novel technologies for high-throughput genotyping will permit to determine the genetic influence of related phenotypes in patients with PNSV.Keywords
This publication has 117 references indexed in Scilit:
- Identification of Multiple Genetic Susceptibility Loci in Takayasu ArteritisThe American Journal of Human Genetics, 2013
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- The vasculitic neuropathiesCurrent Opinion in Neurology, 2012
- ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki diseaseThe Pharmacogenomics Journal, 2011
- Diabetic lumbosacral radiculoplexus neuropathy: a postmortem studied patient and review of the literatureJournal of Neurology, 2011
- Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insultActa Neuropathologica, 2010
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisNew England Journal of Medicine, 2010
- Diabetic Neuropathy: A Clinical and Neuropathological Study of 107 PatientsNeurology Research International, 2010
- Wartenberg’s migrant sensory neuritis: a prospective follow-up studyJournal of Neurology, 2010
- Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulinAnnals of Allergy, Asthma & Immunology, 2004